U.S. markets open in 3 hours 20 minutes

  • S&P Futures

    4,233.75
    +24.00 (+0.57%)
     

  • Dow Futures

    33,474.00
    +170.00 (+0.51%)
     

  • Nasdaq Futures

    13,394.75
    +83.50 (+0.63%)
     

  • Russell 2000 Futures

    1,989.50
    +13.20 (+0.67%)
     

  • Crude Oil

    94.58
    +0.24 (+0.25%)
     

  • Gold

    1,802.60
    -4.60 (-0.25%)
     

  • Silver

    20.25
    -0.09 (-0.46%)
     

  • EUR/USD

    1.0294
    -0.0031 (-0.30%)
     

  • 10-Yr Bond

    2.8880
    0.0000 (0.00%)
     

  • Vix

    20.02
    +0.28 (+1.42%)
     

  • GBP/USD

    1.2140
    -0.0062 (-0.51%)
     

  • USD/JPY

    133.4300
    +0.4310 (+0.32%)
     

  • BTC-USD

    23,965.64
    -498.27 (-2.04%)
     

  • CMC Crypto 200

    569.61
    -5.13 (-0.89%)
     

  • FTSE 100

    7,513.59
    +47.68 (+0.64%)
     

  • Nikkei 225

    28,546.98
    +727.65 (+2.62%)
     

Why Kodiak Sciences Stock Is Cratering Today

George Budwell, The Motley Fool
·1 min read
Why Kodiak Sciences Stock Is Cratering Today
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • KOD
  • REGN

What happened Shares of the clinical-stage biotech Kodiak Sciences (NASDAQ: KOD) are down by a hefty 80.3% as of 2:22 p.m. ET Wednesday afternoon. The drugmaker's stock is plunging today in response to its lead product candidate, KSI-301, failing to meet the primary endpoint of a combined phase 2/3 trial as a treatment for wet age-related macular degeneration (wet AMD).

Continue reading

Recommended Stories